ZEVRA THERAPEUTICS INC (ZVRA) Stock Income Statement
USA - NASDAQ:ZVRA - US4884452065 - Common Stock
7.36 USD
-0.39 (-5.03%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 62.02M | 23.61M | 27.46M | 10.46M | 28.65M | |||
| Cost Of Goods | 6.39M | 6.24M | 800.00K | N/A | N/A | |||
| Gross Profit | 55.63M | 17.38M | 26.66M | N/A | N/A | |||
| Operating Expenses | 116.04M | 104.38M | 76.27M | 35.30M | 20.92M | |||
| Research and Development | 25.99M | 42.09M | 39.81M | 19.61M | 10.16M | |||
| Selling, General, and Administrative Expenses | 72.66M | 54.87M | 34.31M | 15.34M | 8.70M | |||
| Operating Income | -60.41M | -87.00M | -49.60M | -24.85M | 7.73M | |||
| Interest Income/Expense | -4.58M | -5.19M | 3.56M | 180.00K | -150.00K | |||
| Other Income/Expense | -3.22M | 2.06M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | -17.66M | -16.10M | |||
| Income Before Taxes | 21.40M | -90.14M | -46.05M | -42.33M | -8.52M | |||
| Income Tax | 18.75M | 15.37M | 0.00 | -790.00K | 30.00K | |||
| Net Income | 2.64M | -105.51M | -46.05M | -41.54M | -62.90M | |||
| EBITDA | -53.85M | -80.61M | -48.60M | -23.91M | 7.99M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -2.28 | -1.30 | -1.20 | -2.11 | |||
| Non GAAP EPS | -0.23 | -2.26 | -1.29 | -0.69 | -0.46 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.69% | 73.59% | 97.09% | N/A | N/A | |||
| Profit Margin | 4.26% | -446.85% | -167.69% | -397.13% | -219.55% | |||
| Operating Profit Margin | -97.41% | -368.47% | -180.63% | -237.57% | 26.98% | |||
All data in USD